Literature DB >> 3458670

A biochemical characterization of feline MHC products: unusually high expression of class II antigens on peripheral blood lymphocytes.

J J Neefjes, E J Hensen, T I de Kroon, H L Ploegh.   

Abstract

The polymorphism of feline MHC antigens was examined using biochemical methods. The following observations were made: (1) feline class I and II antigens are polymorphic. Their biochemical features were established using rabbit and mouse reagents directed against human MHC products; they resemble those observed for other mammalian species; (2) the expression of class II antigens in unstimulated cat peripheral blood lymphocytes (PBLs) appears to be unusually high. Cat PBLs express far more class II than class I antigens, whereas in human Epstein-Barr virus-transformed lines, which are known to express relatively large amounts of class II antigens, the situation is reversed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3458670     DOI: 10.1007/BF00398799

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  29 in total

1.  The effects of methylnitrosourea on the immune system and hematopoietic system of adult specific pathogen free cats.

Authors:  M J Tarr; R G Olsen; E A Hoover; G J Kociba; J P Schaller
Journal:  Chem Biol Interact       Date:  1979-12       Impact factor: 5.192

2.  An improved biochemical method for the analysis of HLA-class I antigens. Definition of new HLA-class I subtypes.

Authors:  J J Neefjes; B S Breur-Vriesendorp; G A van Seventer; P Iványi; H L Ploegh
Journal:  Hum Immunol       Date:  1986-06       Impact factor: 2.850

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Refinement of HLA gene mapping with induced B-cell line mutants.

Authors:  B Spring; C Fonatsch; C Müller; G Pawelec; J Kömpf; P Wernet; A Ziegler
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

5.  Analysis of human class I antigens by two-dimensional gel electrophoresis. I. Polymorphism, evidence for additional (non-HLA-A, B, C) gene products, and identification of variant HLA-A, B antigens.

Authors:  R G Vasilov; A Hahn; H Mölders; J J van Rood; M Breuning; H L Ploegh
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

6.  Phase separation of integral membrane proteins in Triton X-114 solution.

Authors:  C Bordier
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

7.  Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon.

Authors:  J S Pober; T Collins; M A Gimbrone; R S Cotran; J D Gitlin; W Fiers; C Clayberger; A M Krensky; S J Burakoff; C S Reiss
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

8.  Nomenclature for chicken major histocompatibility (B) complex.

Authors:  W E Briles; N Bumstead; D L Ewert; D G Gilmour; J Gogusev; K Hála; C Koch; B M Longenecker; A W Nordskog; J R Pink; L W Schierman; M Simonsen; A Toivanen; P Toivanen; O Vainio; G Wick
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

9.  Increased synthesis and expression of H-2 antigens on thymocytes as a result of radiation leukemia virus infection: a possible mechanism for H-2 linked control of virus-induced neoplasia.

Authors:  D Meruelo; S H Nimelstein; P P Jones; M Lieberman; H O McDevitt
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

10.  Analysis of H-2 and Ia molecules by two-dimensional gel electrophoresis.

Authors:  P P Jones
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

View more
  16 in total

1.  Recycling MHC class I molecules and endosomal peptide loading.

Authors:  M Grommé; F G Uytdehaag; H Janssen; J Calafat; R S van Binnendijk; M J Kenter; A Tulp; D Verwoerd; J Neefjes
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

2.  Immunohistochemical analysis of mucosal gamma-interferon production in coeliac disease.

Authors:  A al-Dawoud; I Nakshabendi; A Foulis; A M Mowat
Journal:  Gut       Date:  1992-11       Impact factor: 23.059

3.  Cloning, expression, and characterization of fugu CD4, the first ectothermic animal CD4.

Authors:  Hiroaki Suetake; Kyosuke Araki; Yuzuru Suzuki
Journal:  Immunogenetics       Date:  2004-07-28       Impact factor: 2.846

4.  The primary structure of a feline class I gene: striking similarity to HLA-A.

Authors:  M van Hoof; J P de Geus; M Roos; C Brown; H Jacobs; H Ploegh
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Structure and polymorphism of the feline complement component C4.

Authors:  A I de Kroon; G Doxiadis; I Doxiadis; E J Hensen
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

Review 6.  Class I major histocompatibility complex genes in vertebrate species: what is the common denominator?

Authors:  T J Kindt; D S Singer
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

7.  Spatial correlation between thyroid epithelial cells expressing class II MHC molecules and interferon-gamma-containing lymphocytes in human thyroid autoimmune disease.

Authors:  F Hamilton; M Black; M A Farquharson; C Stewart; A K Foulis
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

8.  Polymorphisms and tissue expression of the feline leukocyte antigen class I loci FLAI-E, FLAI-H, and FLAI-K.

Authors:  Jennifer C Holmes; Savannah G Holmer; Peter Ross; Adam S Buntzman; Jeffrey A Frelinger; Paul R Hess
Journal:  Immunogenetics       Date:  2013-06-30       Impact factor: 2.846

9.  A feline class II alpha gene with striking similarity to the HLA-DPA pseudogene.

Authors:  A J Verhoeven; M H Roos; H L Ploegh
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

10.  Genetic characterization of FLA, the cat major histocompatibility complex.

Authors:  C Winkler; A Schultz; S Cevario; S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.